2009
DOI: 10.1111/j.1365-2230.2008.03095.x
|View full text |Cite
|
Sign up to set email alerts
|

Pityriasis rubra pilaris type 1 spontaneously resolving after 20 years

Abstract: Pityriasis rubra pilaris (PRP) is an uncommon, idiopathic, papulosquamous eruption. We report a longitudinal study of a patient with PRP type 1 who was treated with retinoid therapy for 9 years and whose symptoms resolved spontaneously after 20 years. There are no data in the literature on the disease course of PRP type 1 persisting beyond the usual 3 years. This case highlights both the extreme chronicity of PRP and the possibility of remission after many years of active disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0
1

Year Published

2010
2010
2019
2019

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 4 publications
0
11
0
1
Order By: Relevance
“…These findings clearly suggest that PRP, while in some cases a readily self-limiting condition, can persist well beyond the anticipated 2–3 years course in other cases. 11 In fact, the natural history of this seems to be more variable than previously realized. This has obvious implications when counseling newly diagnosed patients.…”
Section: Discussionmentioning
confidence: 95%
“…These findings clearly suggest that PRP, while in some cases a readily self-limiting condition, can persist well beyond the anticipated 2–3 years course in other cases. 11 In fact, the natural history of this seems to be more variable than previously realized. This has obvious implications when counseling newly diagnosed patients.…”
Section: Discussionmentioning
confidence: 95%
“…5,6 PRP type I is considered a self-limiting disease, albeit with spontaneous resolution after an average of 3 years and occasionally with long protracted course up to 20 years. 7 In type II PRP, which runs on a chronic course, long-term etanercept treatment for 12 months maintained persistent clearing of skin lesions, with a disease-free interval of 2 months after drug-withdrawal. While effective in controlling disease manifestations (erythroderma) in both types of PRP, etanercept treatment did not change the chronic course of type II PRP.…”
Section: Discussionmentioning
confidence: 99%
“…Long‐term follow‐up is necessary because of possible relapse in 20% of PRP type I cases, risk of a chronic course and evolution to circumscribed PRP and psoriasis 5,6 . PRP type I is considered a self‐limiting disease, albeit with spontaneous resolution after an average of 3 years and occasionally with long protracted course up to 20 years 7 . In type II PRP, which runs on a chronic course, long‐term etanercept treatment for 12 months maintained persistent clearing of skin lesions, with a disease‐free interval of 2 months after drug‐withdrawal.…”
Section: Discussionmentioning
confidence: 99%
“…Specifically only in seven cases was a skin biopsy taken, with most of the earlier reported cases having no histological evidence of PRP. Secondly, we know that 80% of PRP individuals clear within 3 years 2 although a single case of spontaneous resolution after 20 years has been reported 19 . There is therefore the possibility that in some of the cases reported, the resolution of disease may not necessarily be attributable to treatment, but rather represent spontaneous resolution.…”
Section: Discussionmentioning
confidence: 99%